Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Šmarda J[au]:

Cyanobacterial ultrastructure in light of genomic sequence data. Gonzalez-Esquer CR et al. Photosynth Res. (2016)

Role of c-Myb in chondrogenesis. Oralová V et al. Bone. (2015)

Anti-cancer effects of wedelolactone: interactions with copper and subcellular localization. Kučírková T et al. Metallomics. (2018)

Search results

Items: 1 to 50 of 152

1.

Drug Penetration Analysis in 3D Cell Cultures Using Fiducial-Based Semiautomatic Coregistration of MALDI MSI and Immunofluorescence Images.

Machálková M, Pavlatovská B, Michálek J, Pruška A, Štěpka K, Nečasová T, Radaszkiewicz KA, Kozubek M, Šmarda J, Preisler J, Navrátilová J.

Anal Chem. 2019 Nov 5;91(21):13475-13484. doi: 10.1021/acs.analchem.9b02462. Epub 2019 Oct 17.

PMID:
31584797
2.

Low infiltration of tumor-associated macrophages in high c-Myb-expressing breast tumors.

Volodko N, Gutor T, Petronchak O, Huley R, Dúcka M, Šmarda J, Borsig L, Beneš P, Knopfová L.

Sci Rep. 2019 Aug 12;9(1):11634. doi: 10.1038/s41598-019-48051-1.

3.

High c-Myb Expression Associates with Good Prognosis in Colorectal Carcinoma.

Tichý M, Knopfová L, Jarkovský J, Vlček P, Katolická J, Čapov I, Hermanová M, Šmarda J, Beneš P.

J Cancer. 2019 Feb 23;10(6):1393-1397. doi: 10.7150/jca.29530. eCollection 2019.

4.

MALDI MS Imaging at Acquisition Rates Exceeding 100 Pixels per Second.

Bednařík A, Machálková M, Moskovets E, Coufalíková K, Krásenský P, Houška P, Kroupa J, Navrátilová J, Šmarda J, Preisler J.

J Am Soc Mass Spectrom. 2019 Feb;30(2):289-298. doi: 10.1007/s13361-018-2078-8. Epub 2018 Nov 19.

PMID:
30456596
5.

Anti-cancer effects of wedelolactone: interactions with copper and subcellular localization.

Kučírková T, Stiborek M, Dúcka M, Navrátilová J, Bogdanović Pristov J, Popović-Bijelić A, Vojvodić S, Preisler J, Kanický V, Šmarda J, Spasojević I, Beneš P.

Metallomics. 2018 Oct 17;10(10):1524-1531. doi: 10.1039/c8mt00191j. Epub 2018 Sep 21.

PMID:
30238942
6.

Escherichia coli isolates from patients with inflammatory bowel disease: ExPEC virulence- and colicin-determinants are more frequent compared to healthy controls.

Micenková L, Frankovičová L, Jaborníková I, Bosák J, Dítě P, Šmarda J, Vrba M, Ševčíková A, Kmeťová M, Šmajs D.

Int J Med Microbiol. 2018 Jul;308(5):498-504. doi: 10.1016/j.ijmm.2018.04.008. Epub 2018 May 1.

PMID:
29735381
7.

Transcription factor c-Myb inhibits breast cancer lung metastasis by suppression of tumor cell seeding.

Knopfová L, Biglieri E, Volodko N, Masařík M, Hermanová M, Glaus Garzón JF, Dúcka M, Kučírková T, Souček K, Šmarda J, Beneš P, Borsig L.

Oncogene. 2018 Feb 22;37(8):1020-1030. doi: 10.1038/onc.2017.392. Epub 2017 Oct 30.

8.

Complex analysis of the TP53 tumor suppressor in mantle cell and diffuse large B-cell lymphomas.

Zlamalikova L, Moulis M, Ravcukova B, Liskova K, Malcikova J, Salek D, Jarkovsky J, Svitakova M, Hrabalkova R, Smarda J, Smardova J.

Oncol Rep. 2017 Oct;38(4):2535-2542. doi: 10.3892/or.2017.5891. Epub 2017 Aug 8.

PMID:
28791403
9.

Complete Genome Sequence of Bacteriophage SEN8, a Temperate Phage Isolated from Salmonella enterica subsp. salamae.

Bosák J, Mikalová L, Čejková D, Šmarda J, Šmajs D.

Genome Announc. 2017 May 11;5(19). pii: e00239-17. doi: 10.1128/genomeA.00239-17.

10.

Wedelolactone Acts as Proteasome Inhibitor in Breast Cancer Cells.

Nehybová T, Šmarda J, Daniel L, Stiborek M, Kanický V, Spasojevič I, Preisler J, Damborský J, Beneš P.

Int J Mol Sci. 2017 Mar 29;18(4). pii: E729. doi: 10.3390/ijms18040729.

11.

Selective elimination of neuroblastoma cells by synergistic effect of Akt kinase inhibitor and tetrathiomolybdate.

Navrátilová J, Karasová M, Kohutková Lánová M, Jiráková L, Budková Z, Pacherník J, Šmarda J, Beneš P.

J Cell Mol Med. 2017 Sep;21(9):1859-1869. doi: 10.1111/jcmm.13106. Epub 2017 Feb 28.

12.

Novel Temperate Phages of Salmonella enterica subsp. salamae and subsp. diarizonae and Their Activity against Pathogenic S. enterica subsp. enterica Isolates.

Mikalová L, Bosák J, Hříbková H, Dědičová D, Benada O, Šmarda J, Šmajs D.

PLoS One. 2017 Jan 24;12(1):e0170734. doi: 10.1371/journal.pone.0170734. eCollection 2017.

13.

Osteogenic Potential of the Transcription Factor c-MYB.

Oralova V, Matalova E, Killinger M, Knopfova L, Smarda J, Buchtova M.

Calcif Tissue Int. 2017 Mar;100(3):311-322. doi: 10.1007/s00223-016-0219-2. Epub 2016 Dec 24.

PMID:
28012106
14.

Cyanobacterial ultrastructure in light of genomic sequence data.

Gonzalez-Esquer CR, Smarda J, Rippka R, Axen SD, Guglielmi G, Gugger M, Kerfeld CA.

Photosynth Res. 2016 Aug;129(2):147-57. doi: 10.1007/s11120-016-0286-2. Epub 2016 Jun 25. Review.

PMID:
27344651
15.

c-Myb regulates NOX1/p38 to control survival of colorectal carcinoma cells.

Pekarčíková L, Knopfová L, Beneš P, Šmarda J.

Cell Signal. 2016 Aug;28(8):924-36. doi: 10.1016/j.cellsig.2016.04.007. Epub 2016 Apr 20.

PMID:
27107996
16.

A combined morphological, ultrastructural, molecular, and biochemical study of the peculiar family Gomontiellaceae (Oscillatoriales) reveals a new cylindrospermopsin-producing clade of cyanobacteria.

Bohunická M, Mareš J, Hrouzek P, Urajová P, Lukeš M, Šmarda J, Komárek J, Gaysina LA, Strunecký O.

J Phycol. 2015 Dec;51(6):1040-54. doi: 10.1111/jpy.12354. Epub 2015 Nov 16.

PMID:
26987000
17.

Expression of D-type cyclins in mantle cell and diffuse large B-cell lymphomas.

Zlamalikova L, Moulis M, Salek D, Jarkovsky J, Smarda J, Smardova J.

Oncol Rep. 2016 May;35(5):2673-80. doi: 10.3892/or.2016.4658. Epub 2016 Mar 7.

PMID:
26985765
18.

Dietary fatty acids specifically modulate phospholipid pattern in colon cells with distinct differentiation capacities.

Hofmanová J, Slavík J, Ovesná P, Tylichová Z, Vondráček J, Straková N, Vaculová AH, Ciganek M, Kozubík A, Knopfová L, Šmarda J, Machala M.

Eur J Nutr. 2017 Jun;56(4):1493-1508. doi: 10.1007/s00394-016-1196-y. Epub 2016 Mar 16.

PMID:
26983609
19.

Overexpression of c-Myb is associated with suppression of distant metastases in colorectal carcinoma.

Tichý M, Knopfová L, Jarkovský J, Pekarčíková L, Veverková L, Vlček P, Katolická J, Čapov I, Hermanová M, Šmarda J, Beneš P.

Tumour Biol. 2016 Aug;37(8):10723-9. doi: 10.1007/s13277-016-4956-7. Epub 2016 Feb 12.

PMID:
26873484
20.

Enzymatically active cathepsin D sensitizes breast carcinoma cells to TRAIL.

Jancekova B, Ondrouskova E, Knopfova L, Smarda J, Benes P.

Tumour Biol. 2016 Aug;37(8):10685-96. doi: 10.1007/s13277-016-4958-5. Epub 2016 Feb 11.

PMID:
26867770
21.

Complex analysis of the p53 tumor suppressor in lung carcinoma.

Smardova J, Liskova K, Ravcukova B, Malcikova J, Hausnerova J, Svitakova M, Hrabalkova R, Zlamalikova L, Stano-Kozubik K, Blahakova I, Speldova J, Jarkovsky J, Smarda J.

Oncol Rep. 2016 Mar;35(3):1859-67. doi: 10.3892/or.2015.4533. Epub 2015 Dec 29.

PMID:
26718964
22.

Wedelolactone induces growth of breast cancer cells by stimulation of estrogen receptor signalling.

Nehybova T, Smarda J, Daniel L, Brezovsky J, Benes P.

J Steroid Biochem Mol Biol. 2015 Aug;152:76-83. doi: 10.1016/j.jsbmb.2015.04.019. Epub 2015 Apr 28.

PMID:
25934092
23.

Role of c-Myb in chondrogenesis.

Oralová V, Matalová E, Janečková E, Drobná Krejčí E, Knopfová L, Šnajdr P, Tucker AS, Veselá I, Šmarda J, Buchtová M.

Bone. 2015 Jul;76:97-106. doi: 10.1016/j.bone.2015.02.031. Epub 2015 Apr 4.

PMID:
25845979
24.

Mesenchymal stromal cell labeling by new uncoated superparamagnetic maghemite nanoparticles in comparison with commercial Resovist--an initial in vitro study.

Skopalik J, Polakova K, Havrdova M, Justan I, Magro M, Milde D, Knopfova L, Smarda J, Polakova H, Gabrielova E, Vianello F, Michalek J, Zboril R.

Int J Nanomedicine. 2014 Nov 20;9:5355-72. doi: 10.2147/IJN.S66986. eCollection 2014.

25.

Mouse Incisor Stem Cell Niche and Myb Transcription Factors.

Svandova E, Vesela B, Smarda J, Hampl A, Radlanski RJ, Matalova E.

Anat Histol Embryol. 2015 Oct;44(5):338-44. doi: 10.1111/ahe.12145. Epub 2014 Sep 3.

PMID:
25182175
26.

Mybs in mouse hair follicle development.

Veselá B, Svandová E, Smarda J, Matalová E.

Tissue Cell. 2014 Oct;46(5):352-5. doi: 10.1016/j.tice.2014.06.006. Epub 2014 Jul 2.

PMID:
25064514
27.

Plant coumestans: recent advances and future perspectives in cancer therapy.

Nehybová T, Šmarda J, Beneš P.

Anticancer Agents Med Chem. 2014;14(10):1351-62. Review.

PMID:
25019627
28.

[Techniques to study transendothelial migration in vitro].

Knopfová L, Bouchal P, Smarda J.

Klin Onkol. 2014;27 Suppl 1:S28-33. Review. Czech.

PMID:
24945534
29.

[The use of flow cytometry for analysis of the mitochondrial cell death].

Pekarčíková L, Knopfová L, Ondroušková E, Smarda J.

Klin Onkol. 2014;27 Suppl 1:S15-21. Czech.

PMID:
24945532
30.

Acidic pH of tumor microenvironment enhances cytotoxicity of the disulfiram/Cu2+ complex to breast and colon cancer cells.

Navrátilová J, Hankeová T, Beneš P, Šmarda J.

Chemotherapy. 2013;59(2):112-20. doi: 10.1159/000353915. Epub 2013 Sep 14.

PMID:
24051574
31.

Low-glucose conditions of tumor microenvironment enhance cytotoxicity of tetrathiomolybdate to neuroblastoma cells.

Navrátilová J, Hankeová T, Beneš P, Smarda J.

Nutr Cancer. 2013;65(5):702-10. doi: 10.1080/01635581.2013.789118.

PMID:
23859038
32.

Human Escherichia coli strains of different geographical and time source: bacteriocin types and their gene sequences are population-specific.

Smajs D, Cejková D, Micenková L, Lima-Bittencourt CI, Chartone-Souza E, Smarda J, Nascimento AM.

Environ Microbiol Rep. 2012 Aug;4(4):459-66. doi: 10.1111/j.1758-2229.2012.00365.x. Epub 2012 Jul 3.

PMID:
23760833
33.

Nuclear factor of activated T-cells 1 increases sensitivity of v-myb transformed monoblasts to all-trans retinoic acid.

Trčka F, Šmarda J, Knopfová L, Kuziaková K, Beneš P.

Cell Signal. 2013 Jul;25(7):1546-55. doi: 10.1016/j.cellsig.2013.03.021. Epub 2013 Apr 6.

PMID:
23571271
34.

High frequency of temperature-sensitive mutants of p53 in glioblastoma.

Smardova J, Liskova K, Ravcukova B, Kubiczkova L, Sevcikova S, Michalek J, Svitakova M, Vybihal V, Kren L, Smarda J.

Pathol Oncol Res. 2013 Jul;19(3):421-8. doi: 10.1007/s12253-012-9596-7. Epub 2013 Mar 28.

PMID:
23536279
35.

Localization of c-MYB in differentiated cells during postnatal molar and alveolar bone development.

Lungova V, Buchtova M, Janeckova E, Tucker AS, Knopfova L, Smarda J, Matalova E.

Eur J Oral Sci. 2012 Dec;120(6):495-504. doi: 10.1111/j.1600-0722.2012.01004.x. Epub 2012 Oct 4.

PMID:
23167465
36.

Roscovitine-induced apoptosis of H1299 cells depends on functional status of p53.

Slovackova J, Smarda J, Smardova J.

Neoplasma. 2012;59(6):606-12. doi: 10.4149/neo_2012_077.

PMID:
22862161
37.

Redox state alters anti-cancer effects of wedelolactone.

Benes P, Alexova P, Knopfova L, Spanova A, Smarda J.

Environ Mol Mutagen. 2012 Aug;53(7):515-24. doi: 10.1002/em.21712. Epub 2012 Jun 26.

PMID:
22733624
38.

Transactivation and reactivation capabilities of temperature-dependent p53 mutants in yeast and human cells.

Jagosova J, Pitrova L, Slovackova J, Ravcukova B, Smarda J, Smardova J.

Int J Oncol. 2012 Sep;41(3):1157-63. doi: 10.3892/ijo.2012.1520. Epub 2012 Jun 15.

PMID:
22710932
39.

Clinical correlations of miR-21 expression in colorectal cancer patients and effects of its inhibition on DLD1 colon cancer cells.

Faltejskova P, Besse A, Sevcikova S, Kubiczkova L, Svoboda M, Smarda J, Kiss I, Vyzula R, Slaby O.

Int J Colorectal Dis. 2012 Nov;27(11):1401-8. doi: 10.1007/s00384-012-1461-3. Epub 2012 Apr 3.

PMID:
22476768
40.

c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis.

Knopfová L, Beneš P, Pekarčíková L, Hermanová M, Masařík M, Pernicová Z, Souček K, Smarda J.

Mol Cancer. 2012 Mar 23;11:15. doi: 10.1186/1476-4598-11-15.

41.

Novel colicin Fy of Yersinia frederiksenii inhibits pathogenic Yersinia strains via YiuR-mediated reception, TonB import, and cell membrane pore formation.

Bosák J, Laiblová P, Smarda J, Dedicová D, Smajs D.

J Bacteriol. 2012 Apr;194(8):1950-9. doi: 10.1128/JB.05885-11. Epub 2012 Feb 17.

42.

Experimental administration of the probiotic Escherichia coli strain Nissle 1917 results in decreased diversity of E. coli strains in pigs.

Smajs D, Bureš J, Smarda J, Chaloupková E, Květina J, Förstl M, Kohoutová D, Kuneš M, Rejchrt S, Lesná J, Kopáčová M.

Curr Microbiol. 2012 Mar;64(3):205-10. doi: 10.1007/s00284-011-0051-x. Epub 2011 Nov 25.

PMID:
22116501
43.

Expression and characterization of c-Myb in prenatal odontogenesis.

Matalová E, Buchtová M, Tucker AS, Bender TP, Janečková E, Lungová V, Balková S, Smarda J.

Dev Growth Differ. 2011 Aug;53(6):793-803. doi: 10.1111/j.1440-169X.2011.01287.x. Epub 2011 Jul 18.

PMID:
21762405
44.

Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli Nissle.

Bures J, Smajs D, Kvetina J, Förstl M, Smarda J, Kohoutova D, Kunes M, Cyrany J, Tacheci I, Rejchrt S, Lesna J, Vorisek V, Kopacova M.

World J Gastroenterol. 2011 Feb 7;17(5):609-17. doi: 10.3748/wjg.v17.i5.609.

45.

Inhibition of topoisomerase IIα: novel function of wedelolactone.

Benes P, Knopfova L, Trcka F, Nemajerova A, Pinheiro D, Soucek K, Fojta M, Smarda J.

Cancer Lett. 2011 Apr 1;303(1):29-38. doi: 10.1016/j.canlet.2011.01.002.

PMID:
21315506
46.

Bacteriocin synthesis in uropathogenic and commensal Escherichia coli: colicin E1 is a potential virulence factor.

Smajs D, Micenková L, Smarda J, Vrba M, Sevčíková A, Vališová Z, Woznicová V.

BMC Microbiol. 2010 Nov 15;10:288. doi: 10.1186/1471-2180-10-288.

47.

Transactivation by temperature-dependent p53 mutants in yeast and human cells.

Slovackova J, Grochova D, Navratilova J, Smarda J, Smardova J.

Cell Cycle. 2010 Jun 1;9(11):2141-8. Epub 2010 Jun 1.

PMID:
20505364
48.

The use of Cox-2 and PPARγ signaling in anti-cancer therapies.

Knopfová L, Smarda J.

Exp Ther Med. 2010 Mar;1(2):257-264. Epub 2010 Mar 1.

49.

Copper ions regulate cytotoxicity of disulfiram to myeloid leukemia cells.

Navrátilová J, Jungová P, Vanhara P, Preisler J, Kanicky V, Smarda J.

Int J Mol Med. 2009 Nov;24(5):661-70.

PMID:
19787200
50.

Growth/differentiation factor-15 inhibits differentiation into osteoclasts--a novel factor involved in control of osteoclast differentiation.

Vanhara P, Lincová E, Kozubík A, Jurdic P, Soucek K, Smarda J.

Differentiation. 2009 Nov;78(4):213-22. doi: 10.1016/j.diff.2009.07.008. Epub 2009 Aug 19.

PMID:
19695766

Supplemental Content

Loading ...
Support Center